Leafix Medical
Transcatheter Solution to Functional Mitral Regurgitation
Startup Seed Health Tech & Life Sciences Est. 2025
Total Raised
$6.5M
Seed
Last Round
$5M
2 rounds
Investors
1
1 public
Team
1
1-10 employees
Confidence
80/100
News
1
articles
About
LeaFix developed the only Transcatheter Functional Mitral valve Regurgitation repair solution, performed by an augmentation of the anterior leaflet. The system is composed of an implant and a delivery system, used for implantation of an implant into the anterior leaflet while expanding the implant within the leaflet, hence enlarging the leaflet area and creating coaptation of the leaflets.
Classification
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Core Technology
Materials & SubstancesImplants
Target Customer
Healthcare & Life SciencesHealthcareProviders
Business Model
B2B
Tags
cardiovascularcatheterscardiology
Funding & Events
Jul 2025
Seed $5M
Pitango HealthTech (Lead)
Jan 2025
Non-equity $1.5M
Israel Innovation Authority (Lead)
News (1)
Jul 29, 2025 ยท www.calcalist.co.il
ืฉื ื” ืœืื—ืจ ื”ืืงื–ื™ื˜ ื”ืขื ืง: ืžื ืชื— ื”ืœื‘ ื—ื•ืฉืฃ ืกื˜ืืจื˜-ืืค ื—ื“ืฉ
Details
Product Stage
R&D
Employees
1-10
Exact Count
5
District
Center District
Founded
2025
Registrar
517093431
Locations
Givat Brenner, Israel
Links
Admin
Last Update
Aug 25, 2025
Verified by
Yanina Wainscheinker
Missing
sector, video or image, markets, not claimed
Team (1)
Ron Szekely
Co-founder & CEO
Founder
Internal
Created by
Jenny Sotnik-Talisman (jenny.sotnik@sncentral.org)
Created
2025-02-20T00:00:00.000Z